protocol gobi new

22
TO ESTIMATE THE MINIMUM EFFECTIVE VOLUME OF LIGNOCAINE-BUPIVACAINE MIXTURE FOR ULTRASOUND GUIDED MULTIPOINT SUBFASCIAL SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK DR.GOBINATH J R EG . N O : 1601021002 | MAY/2016 OF A DMISSION | MAY/2019 OF E XAMINATION MD(ANAESTHESIOLOGY),MGMCRI GUIDE D R . SRIPRIYA. R A SSOCIATE P ROFESSOR DEPARTMENT OF ANAESTHESIOLOGY, MGMCRI Co-GUIDE DR.CHARULATHA .R A SSISTANT P ROFESSOR DEPARTMENT OF ANAESTHESIOLOGY, MGMCRI

Upload: harith-daggupati

Post on 16-Apr-2017

34 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: Protocol gobi   new

TO ESTIMATE THE MINIMUM EFFECTIVE VOLUME OF LIGNOCAINE-BUPIVACAINE

MIXTURE FOR ULTRASOUND GUIDED MULTIPOINT SUBFASCIAL

SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

DR.GOBINATH JREG. NO: 1601021002 | MAY/2016 OF ADMISSION | MAY/2019OF

EXAMINATION

MD(ANAESTHESIOLOGY),MGMCRI

GUIDEDR. SRIPRIYA. R

ASSOCIATE PROFESSOR

DEPARTMENT OF ANAESTHESIOLOGY, MGMCRI

Co-GUIDEDR.CHARULATHA .R

ASSISTANT PROFESSOR

DEPARTMENT OF ANAESTHESIOLOGY, MGMCRI

Co-GUIDE

Page 2: Protocol gobi   new

DR. SIVASHANMUGAM.TPROFESSOR & HEAD

DEPARTMENT OF ANAESTHESIOLOGY

MAHATMA GANDHI MEDICAL COLLEGE & RESEARCH

INSTITUTE

CANDIDATE

Candidate Name : GOBINATH

Course of Study : MD ANAESTHESIOLOGY

University Identity No : 1601021002

Mobile Phone No : +918098023218

E-mail Address : [email protected]

Month/Yr of Admission : MAY 2016

Month/Yr of Examination : MAY 2019

GUIDES

GUIDE: DR. SRIPRIYA.R

Associate Professor

Anesthesiology

9365815939

[email protected]

CO GUIDE: DR.CHARULATHA

Assistant Professor

Anesthesiology

9894909652

[email protected]

2

Page 3: Protocol gobi   new

CO GUIDE: DR.SIVASHANMUGAM

Professor

Department of Anaesthesiology

9442505567

[email protected]

PART II – THE PROTOCOL

1 INTRODUCTION

“Regional anaesthesia always works-provided you put the right dose of the right drug in the right place.” (1) When blocks were performed under landmark guidance the LA dosage was calculated principally based on the maximal allowable dose, as the deposition of the drugs in close proximity to the nerve was not very precise. By using USG guidance, the right place can now be clearly identified. With better understanding of anatomy of the supraclavicular brachial plexus, the right place of injection of LA in this area has constantly been changing. It is now understood that the brachial plexus in the supraclavicular area is arranged in several clusters & hence Multipoint Subfascial injection of LA can provide consistent blockade of the four nerves supplying the upper limb. [Musculocutaneous nerve, Median nerve, Ulnar nerve and Radial nerve] (2)

When using LA to provide surgical anesthesia , we need to provide

1. Dense blockade

2. The duration of block should be such that it covers the entire duration of surgery and also provides adequate pain relief during the immediate post –operative period.

Our previous experience with supraclavicular brachial plexus block, has shown that lignocaine- bupivacaine combination can satisfy these two requirements.

The previous study by Tran etal, (3)

have reported that 23 ml of the drug combination is the MEV required to produce block in 50 % of patients and MEV 95 is 42 ml.

We are however able to produce block in all patients by using 20 ml of the drug combination.

3

Page 4: Protocol gobi   new

2 AIMS AND OBJECTIVES

Aim : To determine the minimum effective volume of lignocaine- bupivacaine

mixture in producing conduction blockade at 30 minutes.

Primary outcome –volume of mixture that can produce a successful block at 30

minutes.

Secondary outcome- 1. Duration of block

2. Measurement of cross sectional area of brachial plexus.

3 REVIEW OF LITERATURE

Edel Duggan et al have determined the Minimum Effective Volume of Local Anesthetic ( 2% lignocaine with adrenaline and 0.5 % bupivacaine equal mixture) for Ultrasound-Guided Supraclavicular Brachial Plexus Block. Twenty-one adults undergoing elective upper limb surgery received a US-guided supraclavicular block. The minimum effective anesthetic volume in 50% of patients was determined using the Dixon and Massey up-and-down method. The initial volume of local anesthetic injected was 30 mL, which was subsequently varied by 5 mL for each consecutive patient according to the response in the previous patient. The effective volume in 95% of patients (ED95) was calculated using probit transformation and logistic regression. The minimum effective anesthetic volume in 50% and calculated effective volume in 95% of patients were 23 mL ( 13 -39 mL) and 42 mL (19-65 mL) respectively.They concluded that the calculated volume of LA required for US-guided supraclavicular block does not seem to differ from the conventionally recommended volume required for supraclavicular blocks using non US-based nerve localization techniques.

Sivashanmugam et al 2015 compared two different techniques of injecting local anaesthetic drugs under ultrasound guidance for supraclavicular Brachial Plexus Block.They performed a randomised comparative study in 32 patients undergoing upper extremity surgery. A 1:1 mixture of local anaesthetics (2%lignocaine with adrenaline and 0.5%bupivacaine) 25 ml was injected subfascially or extrafascially to the brachial plexus sheath. They assessed the Block Onset time and duration of post operative analgesia.Their study concluded that subfascial injection provided faster onset (7 +3)min than extrafascial (20 + 10 ) min and longer duration of analgesia subfascial (9.3 + 1.4 ) and extra fascial (6.1 + 1.4)hours.

Jae Gyok Song et al have determined the minimum effective volume of mepivacaine

4

Page 5: Protocol gobi   new

for ultrasound-guided supraclavicular block. Thirty patients undergoing forearm and hand surgery received ultrasound-guided supraclavicular block with 1.5% mepivacaine. The initial volume of local anesthetic injected was 24 ml, and local anesthetic volume for the next patient was determined by the response of the previous patient. The next patient received a 3 ml higher volume in the case of the failure of the previous case. If the previous block was successful, the next volume was 3 ml lower. MEV was estimated by the Dixon and Massey up and down method. MEV in 95, 90, and 50% of patients (MEV95, MEV90, and MEV50) were calculated using probit transformation and logistic regression. MEV95 of 1.5% mepivacaine was 17 ml ( 13-42 ml), MEV90 was 15 ml ( 12-34 ml), and MEV50 was 9 ml ( 4-12 ml).

JADRANKA PAVIČIĆ ŠARIĆ et al have studied the effects of age on onset time and duration of sensory blockade in ultrasound guided supraclavicular block. Middle-aged (n = 22) and elderly (n = 22) patients undergoing upper limb surgery received an ultrasound-guided supraclavicular brachial plexus block. The starting volume was 30 ml (50 : 50 mixture, 0.5% levobupivacaine, 2% lidocaine). The minimum effective local anesthetic volume in middle-aged and elderly was 23.0 ml (13.7–32.3) vs. 11.9 ml (9.3–14.6). The difference was statistically significant [ P = 0.027]. They concluded that elderly patients need a reduced minimum effective anaesthetic volume for ultrasound-guided supraclavicular block. Additionally they observed a smaller cross-sectional surface area of brachial plexus in the supraclavicular region in elderly compared to adults.

4 RESEARCH QUESTION OR HYPOTHESIS

By using USG guidance the volume of LA that is required for successful block can

be decreased.

5 SUBJECTS AND METHODS

5.1 STUDY SUBJECTS

The Study Involves HUMANS

5.2 TYPE OF STUDY

5

Page 6: Protocol gobi   new

Interventional trial

5.3 PLACE OF STUDY

DEPARTMENT OF ANAESTHESIOLOGY AND CRITICAL CARE ,

MAHATHMA GANDHI MEDICAL COLLEGE AND RESEARCH CENTRE

5.4 SELECTION PROCESS

5.4.1 STUDY POPULATION

Patients with forearm fractures posted for surgery

5.4.2 VOLUNTEERS RECRUITEMENT PROCESS

NA

5.4.3 INCLUSION CRITERIA

ASA 1/2.

Male patients

20 -40 yrs with forearm fracture.

5.4.4 EXCLUSION CRITERIA

• 1) Patient refusal for the block

• 2) History of bleeding disorders

• 3) Local infection at the site of block

• 4) Pre-existing neurological deficit

• 5) Respiratory compromise.

6

Page 7: Protocol gobi   new

• 6) Known allergy to local anaesthetic drug.

• 7) Patients in whom the supraclavicular sono-anatomy is not clear.

5.4.5 SAMPLING PROCEDURE

Sequential Allocation

5.4.6 STUDY GROUPS

The Number of Groups is: 1

5.4.7 SAMPLE SIZE

NA

5.5 METHODOLOGY / PROCEDURES:

TECHNIQUE

After getting approval from the Hospital ethics committee, patients undergoing

surgeries for forearm bone fractures and fulfilling inclusion and exclusion criteria

will be recruited in the study. All the blocks will be performed in the procedure room

under standard monitoring (electrocardiography, pulse oximetry and non-invasive

blood pressure). An 18-gauge IV line will be secured. An IV sedation of 2mg

midazolam will be given before the ultrasound procedure. The patient will be

positioned with the arms by the side. Blocks will be performed under ultrasound

guidance by using high frequency linear probe. The brachial plexus will be scanned

close to the subclavian artery as a bunch of grapes. The cross sectional area of the

brachial plexus will be measured. The plexus will be approached by a 23G spinal

needle connected to a PMO line and drug taken in a 20ml syringe (DISPOVAN). The

study drug will be injected subfascial at 4 different points. Adequate spread of local

7

Page 8: Protocol gobi   new

anesthetics will be confirmed by USG imaging. Final removal of needle after

injection of drug will be taken as block time.

Sensory Blockade will be assessed on a three point Qualitative Scale for perception

of sensation to Ether soaked cotton.

0 - perceives both touch and cold temperature

1 - perceives only the touch but not the temperature

2 - perceives neither touch nor temperature

Sensory Blockade will be assessed in the territories of Musculocutaneous nerve

(MCN) - Lateral forearm , Median Nerve (MN) – Tip of Middle Finger , Ulnar Nerve

(UN) – Little Finger and Radial Nerve (RN) – Anatomical snuff box.

Motor Blockade will be assessed on a 3 point Qualitative Scale.

0 - Normal Motor Function ( Power 4/5 , 5/5 )

1 - Decreased Motor Function ( Power 3/5 , 2/5 )

2 - No Motor Power (Power 0/5 , 1/5 )

for the Four Terminal Branches(Elbow Flexion - Musculocutaneous Nerve , Thumb

Opposition - Median Nerve , Thumb Adduction - Ulnar Nerve , Thumb Abduction-

Radial Nerve).

Successful block is defined as a composite score of 14/16 with a sensory block of

7/8 at 30 minutes of block. The observer who records the sensory and motor

parameters will be blinded to the volume of LA used.

Dixon and massey’s up and down methodology will be followed to determine the

minimum effective volume in 50% of patients. The first patient will receive a block

volume of 20 ml of 2%lignocaine with adrenaline and 0.5% bupivacaine 50:50

mixture. The volume for the subsequent patient will be determined by success or

failure of the block. The drug volume will be increased by 5 ml in case of block

8

Page 9: Protocol gobi   new

failure and decreased by 5ml in case of block success. This will be continued till 3

consecutive up and downs are observed. After three consecutive up and downs are

observed, the drug volume will be altered by 2.5 ml and study continued till three

consecutive up- downs are observed. The mid point of the down to up values will be

taken as minimum effective volume in 50 % of individuals.

Block failures will be managed by performing rescue blocks distally depending on

the nerve areas spared.

Postoperatively, Patient will be instructed to inform when they experience pain.

Time of first occurrence of pain post operatively will be noted. Block time to

perception of pain will be taken as duration of analgesia. The study will end when

the patient complaints of pain. 1 gm Acetaminophen IV will be given when the

patient complains of pain.

5.5.1 INTERVENTIONS/DRUGS USED

Inj lignocaine with adrenaline 2%, bupivacaine 0.5%.

23 G spinal needle

Route- supraclavicular brachial plexus.

LA sensitivity testing will be done on the day before surgery.

5.5.2 PROCUREMENT OF INVESTIGATIONAL DRUGS,

STORAGE, DISPENSING, ETC.

Click to replace with Text

5.6 STUDY TERMINATION

9

Page 10: Protocol gobi   new

Study will be terminated when three consecutive down to up sequences are observed

with a drug volume difference of 2.5 ml.

6 STUDY VARIABLES

1.

S. No Name of the dependent / independent variables

Scale of measurement (Quantitative / qualitative)

Descriptive / Inferential Statistics to be used

1 Volume of LA used Quanitative Mean volume2 Duration of analgesia Quantitative Mean3 Cross sectional Area of

the brachial plexusQuantitative Mean

6.1 DATA COLLECTION

Data will be collected using predefined data capture form. Secondary Data will be

collected from hospital records. Privacy and Confidentiality will be maintained. All

patient identifiable numbers and information will be stripped and replaced by

anonymous numbers.

6.2 STATISTICAL METHODS

The mid point of the down to up values will be taken as minimum effective volume

in 50 % of individuals.

MEV 95 will be calculated by probit transformation and logistic regression analysis.

7 REFERENCES

1. Denny NM, Harrop-Griffiths W. Location, location, location! Ultrasound imaging in regional anaesthesia. British Journal of Anaesthesia 2005; 94: 1–3

2. Sivashanmugam, T., Suja Ray, M. Ravishankar, V. Jaya, E. Selvam, and Manoj Kumar Karmakar. “Randomized Comparison of Extrafascial Versus Subfascial Injection of Local Anesthetic During Ultrasound-Guided Supraclavicular Brachial Plexus Block.” Regional Anesthesia and Pain Medicine,2015;4:337–43.

10

Page 11: Protocol gobi   new

3. Edel Duggan, Hossam El Beheiry, Anahi Perlas, Mario Lupu, Alina Nuica, Vincent W.S. Chan, and Richard Brull. Minimum Effective Volume of Local Anesthetic for Ultrasound-Guided Supraclavicular Brachial Plexus Block. Reg Anesth Pain Med 2009;34: 215-218

4. Jae Gyok Song, Dae Geun Jeon, Bong Jin Kang, and Kee Keun Park. Minimum effective volume of mepivacaine for ultrasound-guided supraclavicular block. Korean J Anesthesiol 2013 July 65(1): 37-41

8 PRELIMINARY WORK DONE ALREADY

NA

9 ETHICAL ISSUES

This study involves humans and requires frequent testing of sensory and motor

blockade. Only temperature and light touch is used for sensory assessment and

avoids pinprick or crude touch.

10 INFORMED CONSENT PROCEDURE

NAME OF THE RESEARCH PROJECT:

“TO ESTIMATE THE MINIMAL EFFECTIVE VOLUME OF

LIGNOCAINE-BUPIVACAINE MIXTURE FOR ULTRASOUND

GUIDED MULTIPOINT SUBFASCIAL SUPRACLAVICULAR

BRACHIAL PLEXUS BLOCK” We welcome you and thank you for having

accepted our request to consider whether you can participate in our study. This sheet

11

Page 12: Protocol gobi   new

contains the details of the study. The possible risks discomfort and benefits to the

participants are also given.

You can read and understand by yourself; if you wish, we are ready to read and

explain the same to you.

If you do not understand anything or if you want any more details we are ready to provide the same.

1. What is the purpose of the study?

The purpose of this study is to estimate minimal effective volume of LA

mixture in onset and duration of analgesia in ultrasound guided

supraclavicular brachial plexus block,so that it provides better analgesia for

the patients.

2. Who / where this study is being conducted?

This study is being conducted by Dr.Gobinath. Post Graduate

medical student belonging to anaesthesiology department under supervision

of Dr. Sripriya ( Associate Professor) & Dr.Charulatha (Assistant Professor) .

3. Why am I being considered as one of the participant?

Based on indications for upper limb surgery

5. Should I definitely take part in this study?

No. The choice is yours. If you do not wish to participate, you will not be

included in this study; even then you would continue to receive the medical treatment

without any prejudice.

5. If I am participating in this study, what would be my responsibilities?

12

Page 13: Protocol gobi   new

After understanding the details of the study, you should give us written consent. You

have to permit us to utilise your clinical data and co-operation during procedure.

6. Are there any benefits for me / public?

Yes. We can use a lower volume of LA to produce the block.

7. Will there be any discomfort / risks to me?

Yes. Failure rate and risk of complications(pneumothorax

/haemothorax,arterial puncture) which will be taken care with utmost vigilance.

8. Will I be paid for the study?

No. You will not be paid.

9. Will my participating in this study, my personal details will be kept

confidentially?

Yes, confidentiality will be maintained.

10. Will I be informed of this study’s results and findings?

Yes, if you want you can get the details from us.

11. Can I withdraw from this study at any time during the study period?

Yes. You can withdraw at any time during the study period.

13

Page 14: Protocol gobi   new

11 QUALITY CONTROL

Please give Quality Control and Assurance Procedures if applicable

Name of Officer designated by the department for quality control:

DR.SIVASHANMUGAM (Head of the Department )

Designation:HEAD OF DEPARTMENT

Telephone No: 9442505567

E-mail:[email protected]

12 SPONSORSHIPS

a. Sponsors for the study, if any (with address, contact number and email)

b. Outside funding, if any

14

Page 15: Protocol gobi   new

13 INVESTIGATORS DECLARATION

This is to certify that the protocol entitled “TO ESTIMATE THE MINIMAL

EFFECTIVE VOLUME OF LIGNOCAINE-BUPIVACAINE MIXTURE

FOR ULTRASOUND GUIDED MULTIPOINT SUBFASCIAL

SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK” was reviewed by us

for submission to the SBV Institutional Ethics Committee and certified that this

protocol represents an accurate and complete description of the proposed research.

We have read the ICMR guidelines, ICP-GCP guidelines/CPCSEA guidelines/and

other applicable guidelines and undertake to ensure that the rights and welfare of the

study subjects are protected.

The study will be performed as per the approved protocol only. If any deviation is

warranted, the same will be presented to the ethical committee and permission will

be sought. We assure that the study will be terminated immediately in case of any

unforeseen adverse consequences and we will inform the same to the ethical

committee immediately.

Dr. SRIPRIYA RAssociate professorDept.of AnaesthesiologyGuide DD/MM/YYYY

Dr. CHARULATHAAssistant Professor Dept.of AnaesthesiologyCo-guide DD/MM/YYYY

Dr. GOBINATHDepartment of AnaesthesiologyCANDIDATE/PI DD/MM/YYYY

15

Page 16: Protocol gobi   new

Dr. SIVASHANMUGAMHead of Department of Anaesthesiology with Dept. Seal DD/MM/YYYY

16